We are live on
!
Find out more
TCM
TCG Crossover Management Portfolio holdings
AUM
$3.5B
1-Year Est. Return
1,165.83%
This Fund
S&P 500
This Quarter
Est. Return
+25.75%
1 Year Est. Return
+1,165.83%
3 Year Est. Return
+3,168.76%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$3.5B
AUM Growth
+$474M
(+16%)
Cap. Flow
+$174M
Cap. Flow
% of AUM
4.97%
Top 10 Holdings %
Top 10 Hldgs %
60.94%
Holding
54
New
11
Increased
8
Reduced
10
Closed
5
Top Buys
| 1 |
Mirum Pharmaceuticals
MIRM
|
+$94.1M |
| 2 |
Disc Medicine
IRON
|
+$93.1M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
+$85.6M |
| 4 |
Vor Biopharma
VOR
|
+$80M |
| 5 |
Immunovant
IMVT
|
+$72.4M |
Top Sells
| 1 |
RAPT
RAPT Therapeutics
RAPT
|
+$87.5M |
| 2 |
ABVX
Abivax
ABVX
|
+$74.6M |
| 3 |
EyePoint Inc
EYPT
|
+$65.3M |
| 4 |
Structure Therapeutics
GPCR
|
+$53.4M |
| 5 |
Liquidia Corp
LQDA
|
+$48.5M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
EyePoint Inc
EYPT
$1.11B
| – | – |
-3,572,335
| Closed | -$65.3M |
|
|
RAPT
52
DELISTED
RAPT Therapeutics
RAPT
| – | – |
-2,582,408
| Closed | -$87.5M |
|
|
VTYX
53
DELISTED
Ventyx Biosciences
VTYX
| – | – |
-316,195
| Closed | -$2.86M |
|
|
MAZE
54
Maze Therapeutics
MAZE
$1.53B
| – | – |
-173,816
| Closed | -$7.2M |
|
Similar funds
DILIC
IIM
KCM
ACM
BCP
AL
ACA
MSC